TRANSPLANTATION Sirolimus plus calcineurin inhibitors in transplantation

被引:1
作者
Braun, William [1 ]
机构
[1] Cleveland Clin Fdn, Dept Hypertens & Nephrol, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
关键词
CYCLOSPORINE; RECIPIENTS; TACROLIMUS; SURVIVAL;
D O I
10.1038/nrneph.2009.55
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A recent study reported that combination therapy with sirolimus plus either tacrolimus or ciclosporin resulted in effective immunosuppression in high-risk renal allograft recipients. does such combination therapy really represent an advance in immunosuppressive therapy for these individuals?
引用
收藏
页码:252 / 254
页数:4
相关论文
共 16 条
[1]  
DANOVITCH GM, 2005, HDB TRANSPLANTATION, P95
[2]   Comparison of Sirolimus Plus Tacrolimus Versus Sirolimus Plus Cyclosporine in High-Risk Renal Allograft Recipients: Results From an Open-Label, Randomized Trial [J].
Gaber, A. Osama ;
Kahan, Barry D. ;
Van Buren, Charles ;
Schulman, Seth L. ;
Scarola, Joseph ;
Neylan, John F. .
TRANSPLANTATION, 2008, 86 (09) :1187-1195
[3]   Immunosuppressive drugs for kidney transplantation [J].
Halloran, PF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) :2715-2729
[4]   Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus [J].
Hricik, Donald E. ;
Augustine, Joshua J. ;
Knauss, Thomas C. ;
Bodziak, Kenneth A. ;
Aeder, Mark ;
Siegel, Christopher ;
Schulak, James A. .
TRANSPLANTATION, 2007, 83 (03) :277-281
[5]   The clinical benefits of cyclosporine C2-level monitoring: A systematic review [J].
Knight, Simon R. ;
Morris, Peter J. .
TRANSPLANTATION, 2007, 83 (12) :1525-1535
[6]   C2 monitoring strategy for optimising cyclosporin immunosuppression from the neoral®1 formulation [J].
Levy, GA .
BIODRUGS, 2001, 15 (05) :279-290
[7]   Identification of high- and low-risk second kidney grafts [J].
Mahoney, RJ ;
Norman, DJ ;
Colombe, BW ;
Garovoy, MR ;
Leeber, DA .
TRANSPLANTATION, 1996, 61 (09) :1349-1355
[8]   Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. [J].
Mange, KC ;
Joffe, MM ;
Feldman, HI .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :726-731
[9]  
Mazzachi B C, 2000, Clin Lab, V46, P53
[10]   Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus [J].
Meier-Kriesche, HU ;
Schold, JD ;
Srinivas, TR ;
Howard, RJ ;
Fujita, S ;
Kaplan, B .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (09) :2273-2280